BGI Genomics major shareholder adjusts pledged stock for financing

Shenzhen BGI Genomics Co., Ltd. announced that its major shareholder, Shenzhen Bio-Hua Investment Enterprise (Limited Partnership), has adjusted its share pledges. Bio-Hua Investment released 8,650,000 shares, representing 29.06% of its total holdings and 2.07% of the company's total share capital, on September 29, 2025.

Concurrently, Bio-Hua Investment re-pledged 6,740,000 shares, which constitutes 22.64% of its holdings and 1.61% of BGI Genomics' total share capital. The re-pledged shares are for financing, with the pledge effective until the completion of release procedures. China CITIC Bank Co., Ltd. Shenzhen Branch is the pledgee for both transactions.

Following these transactions, Bio-Hua Investment's total pledged shares amount to 24,340,000, representing 81.77% of its total holdings and 5.82% of BGI Genomics' total share capital. The company clarified that the pledged shares do not involve any major asset restructuring or performance compensation obligations and that there is no immediate risk of forced liquidation.